About the Pharmacology and Drug Therapy in Eye Diseases Session
Vision is typically seen as the most crucial of the senses, and it is also the one that most people are most afraid of losing. Vision is frequently regarded as the most important sense that allows a person to work and function independently. The eye is a highly specialized organ that can suffer from a wide variety of diseases. Different anatomical parts of the eye may be affected by both local and systemic disease. The complicated physiology of the retina and the anatomy of the eye render the development of effective treatments complex. Because of the eye's unique anatomy and physiology, delivering drugs to the eye has been a huge difficulty. Topical (e.g., eye drops) and systemic (e.g., tablets) formulations are the least invasive ways for ocular drug administration.
- Ocular Pharmacology
- Pharmacokinetics and Drug Delivery
- Novel Approaches to Delivering Compounds to The Eye
- Sustained-Release Implants, Cell Therapy and Gene Therapy
- Challenges Faced in Drug Development and Delivery
- Drugs Used to Treat Eye Disorders
Topics Covered in Pharmacology and Drug Therapy in Eye Diseases
Topical Eye Drops
Intravitreal Injections
Blood-Retinal Barrier
Anti-VEGF Agents
Ocular Corticosteroids
Sustained-Release Implants
Related Scientific Sessions at IOC 2027
Why Attend the Pharmacology and Drug Therapy in Eye Diseases Conference 2027
Present Your Research
Oral and poster slots for original Pharmacology and Drug Therapy in Eye Diseases work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Pharmacology and Drug Therapy in Eye Diseases research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same program, same certificate.
Join IOC 2027 for the Pharmacology and Drug Therapy in Eye Diseases track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Pharmacology and Drug Therapy in Eye Diseases Conference 2027 — FAQs
What is the Pharmacology and Drug Therapy in Eye Diseases track at IOC 2027?
The Pharmacology and Drug Therapy in Eye Diseases track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Pharmacology and Drug Therapy in Eye Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Pharmacology and Drug Therapy in Eye Diseases sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Pharmacology and Drug Therapy in Eye Diseases are all welcome — whether presenting or attending.
Can I present my research in the Pharmacology and Drug Therapy in Eye Diseases track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Pharmacology and Drug Therapy in Eye Diseases sessions?
Yes. IOC 2027 is a hybrid conference — attend the Pharmacology and Drug Therapy in Eye Diseases track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.